immunotherapy

Hematologist Dr. Yi Lin discusses the use of immunotherapies and other novel approaches to treating multiple myeloma.

The story of how Dawn Botsford conquered melanoma with the support of her family, her Mayo Clinic care team and a clinical trial.

Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.

Cancer experts have been exploring and improving multiple myeloma treatments that can extend periods of remission and enhance quality of life.

A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.  

Adding mRNA therapy improves the response to cancer immunotherapy in people who weren't responding to the treatment, Mayo Clinic research shows.

Systemic therapies for breast cancer include chemotherapy, hormone therapy, targeted-drug therapy and immunotherapy. Medical oncologist Dr. Matthew Goetz provides an overview.

A study by Mayo Clinic researchers finds that immune checkpoint inhibitors may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis.

Keith L. Knutson, Ph.D., an immunologist at Mayo Clinic's campus in Florida and a professor in the Mayo Clinic College of Medicine and Science, discusses his research on the immunology and immunotherapy of breast cancer and ovarian cancer.